Single Dose of Azithromycin Reduces Maternal Sepsis or Death
A UAB-UNC School of Medicine collaboration found that a single oral dose of the common antibiotic azithromycin reduced the risk of maternal sepsis or death by 33 percent in women…
A UAB-UNC School of Medicine collaboration found that a single oral dose of the common antibiotic azithromycin reduced the risk of maternal sepsis or death by 33 percent in women…
News, Pediatrics And Children's Health, School of Medicine, Vital Signs
Rahima Benhabbour, PhD, MSc, associate professor of Biomedical Engineering, led a successful effort to create an injectable implant that can release effective HIV PrEP medications into the body for six…
Led by researchers in the UNC School of Medicine lab of Blossom Damania, PhD, a study in Nature Communications shows how Kaposi sarcoma-associated herpesvirus and Epstein-Barr virus hijack a human…
This research, led by UNC School of Medicine scientists Laura Kincer, Sarah Joseph, PhD, and Ron Swanstrom, PhD, with international collaborators, shows that in addition to HIV’s ability to lay…
Biochemistry, HIV/AIDS, Immunology And Microbiology, News, Research
Led by Pew-Thian Yap, PhD, researchers at the UNC School of Medicine created monthly infant brain atlases to help researchers analyze the developing brain to investigate neurological disorders and other…
Led by graduate student Jeff DiBerto, the UNC School of Medicine lab of Bryan Roth teamed with scientists in China to publish detailed structures of the entire human opioid receptor…
Scientists at the San Francisco VA Medical Center and UC San Francisco, part of a national collaboration led by Sam McLean, MD, MPH, at the UNC School of Medicine, show…
Meghan Rebuli, PhD, an assistant professor of pediatrics in the UNC School of Medicine and member of the Center for Environmental Medicine, Asthma, and Lung Biology, shares new findings and…
News, Pediatrics And Children's Health, Pulmonology, Research
Evan Dellon, MD, MPH, a professor in the Department of Medicine and director of the Center for Esophageal Diseases and Swallowing, co-leads effort to approve an allergy drug, dupilumab, for…
Clinical Research, Gastrointestinal, News, School of Medicine
Led by Jessica Thaxton, PhD, MsCR, UNC School of Medicine scientists and colleagues found that targeting key proteins that control the T cell response to stress could help researchers develop…
The Danish neuroscientist Maiken Nedergaard, MD, DMSc, professor in the department of neurology at the University of Rochester, will receive the Perl-UNC Neuroscience Prize at a ceremony in March.
Awards, Rankings and Recognitions, Research, School of Medicine
The UNC School of Medicine lab of Bryan L. Roth, MD, PhD, solved the high-resolution, complex structures of drug-like compounds bound to designer brain cell receptors, paving the way for…
Led by Jin Szatkiewicz, PhD, UNC School of Medicine researchers and University of Toronto colleagues found that a rare form of a common genetic variant called tandem repeats is strongly…
A new glioblastoma treatment from Northwest Biotherapeutics improved outcomes for many patients in a phase 3 clinical study, according to a study published in JAMA Oncology. Matt Ewend, MD, in…
A new North Carolina study called VISION is now underway to answer some of the biggest questions about COVID-19. Led by William Fischer, MD, principal investigator, and David Wohl, MD,…
Clinical Research, Covid-19 / Coronavirus, Infectious Diseases, News, North Carolina, Research
Researchers at the UNC School of Medicine led by Justin Wolter, PhD, and colleagues at the UNC Eshelman School of Pharmacy and Queen Mary University of London, teamed up to…
UNC Institute for Global Health and Infectious Diseases and critical care experts William Fischer, MD, and David Wohl, MD, in collaboration with UNC Hospitals colleagues, will lead a Regional Emerging…
Awards, Rankings and Recognitions, Emergency Preparedness, Infection Prevention, Infectious Diseases, News, North Carolina
The $8-million dollar DISENTANGLE initiative, led by Sam McLean, MD, MPH, at the UNC School of Medicine and funded through the U.S. Department of Defense, will leverage the latest data…
Depression, Emergency Medicine, News, Psychiatry And Mental Health
A research team from UNC-Chapel Hill, UC San Francisco, Yale, Duke, and Stanford developed a new compound that hits the same brain cell target as psychedelic drugs, triggering long-lasting anti-depressant…
The national GRADE study, with leadership and participation from UNC School of Medicine’s John Buse, MD, PhD, and Sue Kirkman, MD, found that two of four common type 2 diabetes…